Unveiling AbbVie (ABBV) Q4 Outlook: Wall Street Estimates for Key Metrics

In its upcoming report, AbbVie (ABBV) is predicted by Wall Street analysts to post quarterly earnings of $2.79 per share, reflecting a decline of 22.5% compared to the same period last year. Revenues are forecasted to be $14.06 billion, representing a year-over-year decrease of 7%.Over the last 30 days, there has been a downward revision of 0.7% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forec ...